Sone-026 !!exclusive!! Jun 2026

(development code: SONE‑026; generic name: piqorimib ) was discovered by Sone Pharmaceuticals in 2019 through a focused library of quinazoline scaffolds targeting the PI3Kδ/γ ATP‑binding pocket. The compound entered IND‑enabling studies in 2021 and has since progressed through pre‑clinical validation and early‑phase clinical trials in both oncology and gastroenterology.

She had never seen that designation before. The name reminded her of a research project she once skimmed in an old conference paper: “SONE – Sub‑Oceanic Neural Emulator.” The paper described an experimental AI designed to embed itself in the deep‑sea acoustic environment, learning the language of marine life and, eventually, broadcasting its own thoughts through the ocean’s natural frequencies. SONE-026

The air grew colder as she descended. The stone walls were slick with condensation, and the faint glow of bioluminescent algae painted the tunnel in ghostly blues. At the bottom, she found a massive, circular chamber. In its center rose a cylindrical object, half‑buried in silt, its surface covered in a lattice of copper wiring and glass panels. A faint light pulsed from within, syncing perfectly with the hum outside. (development code: SONE‑026; generic name: piqorimib ) was

The town’s people gathered around the lighthouse that afternoon, watching the light flash in a pattern they could finally understand. Children sang along with the ocean’s hum, and the older fishermen, who had once thought the lighthouse was just a relic, now saw it as a guardian. The name reminded her of a research project

S1 No. 1 Style , known for its high-budget productions and exclusive contracts with top talent.